These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections. Hooshmand-Rad R; Reed MD; Chu A; Gotz V; Morris JA; Weinberg J; Dominguez EA Clin Ther; 2004 Oct; 26(10):1652-62. PubMed ID: 15598482 [TBL] [Abstract][Full Text] [Related]
4. Renal effects of amphotericin B lipid complex. Luke RG; Boyle JA Am J Kidney Dis; 1998 May; 31(5):780-5. PubMed ID: 9590187 [TBL] [Abstract][Full Text] [Related]
5. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial. Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses. Wingard JR Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244 [TBL] [Abstract][Full Text] [Related]
7. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain. Aguado JM; Lumbreras C; González-Vidal D; Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408 [TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections. Linden P; Lee L; Walsh TJ Pharmacotherapy; 1999 Nov; 19(11):1261-8. PubMed ID: 10555932 [TBL] [Abstract][Full Text] [Related]
9. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex. Wade RL; Chaudhari P; Natoli JL; Taylor RJ; Nathanson BH; Horn DL Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005 [TBL] [Abstract][Full Text] [Related]
10. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Linden P; Williams P; Chan KM Clin Transplant; 2000 Aug; 14(4 Pt 1):329-39. PubMed ID: 10945204 [TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411 [TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections. Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680 [TBL] [Abstract][Full Text] [Related]
14. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Walsh TJ; Hiemenz JW; Seibel NL; Perfect JR; Horwith G; Lee L; Silber JL; DiNubile MJ; Reboli A; Bow E; Lister J; Anaissie EJ Clin Infect Dis; 1998 Jun; 26(6):1383-96. PubMed ID: 9636868 [TBL] [Abstract][Full Text] [Related]
15. Amphotericin B lipid complex for the treatment of invasive fungal infections. Linden PK Expert Opin Pharmacother; 2003 Nov; 4(11):2099-110. PubMed ID: 14596663 [TBL] [Abstract][Full Text] [Related]
16. Infrequent occurrence of amphotericin B lipid complex-associated nephrotoxicity in various clinical settings at a university hospital: a retrospective study. Slain D; Miller K; Khakoo R; Fisher M; Wierman T; Jozefczyk K Clin Ther; 2002 Oct; 24(10):1636-42. PubMed ID: 12462292 [TBL] [Abstract][Full Text] [Related]
17. Amphotericin B lipid complex to treat invasive fungal infections in cancer patients: report of efficacy and safety in 20 patients. Oravcová E; Mistrík M; Sakalová A; Drgona L; Kollár T; Helpianska L; Ilavská I; Sorkovská D; Spánik S; Kukucková E Chemotherapy; 1995; 41(6):473-6. PubMed ID: 8529439 [TBL] [Abstract][Full Text] [Related]
18. Use of amphotericin B lipid complex in elderly patients. Hooshmand-Rad R; Chu A; Gotz V; Morris J; Batty S; Freifeld A J Infect; 2005 May; 50(4):277-87. PubMed ID: 15845425 [TBL] [Abstract][Full Text] [Related]
19. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies. Mehta J; Kelsey S; Chu P; Powles R; Hazel D; Riley U; Evans C; Newland A; Treleaven J; Singhal S Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254 [TBL] [Abstract][Full Text] [Related]
20. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Chaftari AM; Hachem RY; Ramos E; Kassis C; Campo M; Jiang Y; Prince RA; Wang W; Raad II Transplantation; 2012 Aug; 94(3):302-8. PubMed ID: 22814329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]